Trial Profile
A Phase 1, Open-Label, Single-Sequence Study to Examine the Effect of Telaprevir on the Pharmacokinetics of Buprenorphine in Subjects on Stable Buprenorphine/Naloxone Maintenance Therapy.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2011
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Buprenorphine/naloxone
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Vertex Pharmaceuticals
- 07 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2011 New trial record